STOCK TITAN

Novavax Inc reported $1.1B in revenue and $440.3M in net income for fiscal 2025. See the full NVAX financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

Novavax to Participate in September Investor Conferences

Novavax will host September 2026 fireside chats at Cantor and Citi investor conferences, with live webcasts and 30-day replays for investors.

(Moderate)
(Neutral)
Tags

Novavax (NVAX) will participate in two investor conferences in New York in September 2026, featuring live fireside chat webcasts.

Management will join the 2026 Cantor Global Healthcare Conference on Wednesday, September 9, 2026, at 9:45 a.m. EDT and Citi's 2026 BioPharma Back to School Conference on Thursday, September 10, 2026, at 10:00 a.m. EDT. Webcasts and 30‑day replays will be available on the company’s investor relations website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Market Context

2.32% followed Novavax’s August 28 partnership announcement, giving the platform a recent positive r...
Analysis

2.32% followed Novavax’s August 28 partnership announcement, giving the platform a recent positive reference point outside this scheduling notice. The announcement provides access, but no new financial result is stated; the platform record adds context without establishing an operating catalyst.

Key Figures

Cantor conference date: September 9, 2026 Cantor fireside chat: 9:45 a.m. EDT Citi conference date: September 10, 2026 +2 more
5 metrics
Cantor conference date September 9, 2026 2026 Cantor Global Healthcare Conference
Cantor fireside chat 9:45 a.m. EDT Wednesday, September 9, 2026
Citi conference date September 10, 2026 Citi's 2026 BioPharma Back to School Conference
Citi fireside chat 10:00 a.m. EDT Thursday, September 10, 2026
Webcast replay period 30 days Following each presentation

Historical Context

5 past events · Latest: Aug 28 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Aug 28 Partnership approvals Positive +2.3% Partners secured seasonal vaccine approvals across the U.S., EU and Japan.
Aug 06 2Q26 earnings Negative +0.5% Revenue fell and losses returned despite a raised adjusted revenue framework.
Jul 30 Earnings scheduling Neutral +1.4% Company scheduled a second-quarter results release and investor webcast.
Jun 01 Healthcare conference Neutral -2.9% Novavax announced participation in the Jefferies Global Healthcare Conference.
May 07 Healthcare conference Neutral +9.5% Novavax announced participation in the BofA Securities healthcare conference.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Historical reactions were mixed, with positive responses to the partnership and one conference notice but a negative response to another conference notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

GAITHERSBURG, Md., Sept. 2, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that company management will participate in the following upcoming investor conferences:

  • 2026 Cantor Global Healthcare Conference, New York
    Fireside chat on Wednesday, September 9, 2026, at 9:45 a.m. EDT
  • Citi's 2026 BioPharma Back to School Conference, New York
    Fireside chat on Thursday, September 10, 2026, at 10:00 a.m. EDT

A live webcast of the fireside chats will be available on the "Events & Presentations" page of the Company's website at ir.novavax.com. A replay of each webcast will be available for 30 days following the presentation.

About Novavax

Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M® adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid™, R21/Matrix-M™), Matrix technology and R&D assets. Please visit novavax.com and LinkedIn for more information. 

Contacts:

Investors
Naina Zaman 
844-668-2829 
ir@novavax.com 

Media 
Yvonne Sprow 
844-264-8571 
media@novavax.com 

Novavax Logo

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-september-investor-conferences-302867780.html

SOURCE Novavax, Inc.

FAQ

When will Novavax (NVAX) present at the 2026 Cantor Global Healthcare Conference?

Novavax management will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference in New York on Wednesday, September 9, 2026, at 9:45 a.m. EDT. The session will be accessible via live webcast on the company’s investor relations website.

What are the details of Novavax (NVAX) participation in Citi's 2026 BioPharma Back to School Conference?

Novavax will join Citi's 2026 BioPharma Back to School Conference in New York for a fireside chat on Thursday, September 10, 2026, at 10:00 a.m. EDT. Investors can listen through a live webcast hosted on the Novavax investor relations site.

How can investors access the live webcasts of Novavax (NVAX) September 2026 conference fireside chats?

A live webcast of both fireside chats will be available on the “Events & Presentations” page of Novavax’s investor relations website at ir.novavax.com. This allows investors to follow the discussions in real time online.

Will replays of Novavax (NVAX) September 2026 investor conference webcasts be available?

Yes. A replay of each Novavax fireside chat webcast from the September 2026 Cantor and Citi conferences will be available on the company’s investor relations website for 30 days following each presentation, allowing investors to listen after the live events.